VARKI PAUL (CIK 1677896) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-12). Recent activity: Sell AVTX (1,081 shares), Buy AVTX (62,500 shares), Buy AVTX (12,563 shares), Sell AVTX (37,375 shares), Sell AVTX (5,196 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Avalo Therapeutics, Inc. (AVTX) | Chief Legal Officer | Sell | 1,081 | $14,161 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Legal Officer | Buy | 62,500 | $839,375 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Legal Officer | Buy | 12,563 | $101,007 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Legal Officer | Sell | 37,375 | $706,836 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Legal Officer | Sell | 5,196 | $102,783 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Legal Officer | Sell | 22,839 | $484,541 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Legal Officer | Sell | 9,253 | $210,029 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Legal Officer | Sell | 400 | $9,484 |
| 2025-12-12 | Avalo Therapeutics, Inc. (AVTX) | Chief Legal Officer | Sell | 1,016 | $4,166 |
Source: SEC Form 4 filings · as of 2026-06-12